Neuronetics, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Neuronetics, Inc. (STIM) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $688.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-11
- Neuronetics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $688.00K, a 62.07% decline year-over-year.
- Neuronetics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $1.68M, a 16.14% increase year-over-year.
- Neuronetics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $1.41M, a 0.70% decline year-over-year.
- Neuronetics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $1.81M, a 16.06% increase year-over-year.
- Neuronetics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $6.85M, a 22.24% increase from fiscal 2024.
- Neuronetics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $5.60M, a 23.46% decline from fiscal 2023.
- Neuronetics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $7.32M, a 16.32% decline from fiscal 2022.
- Neuronetics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $8.75M, a 11.14% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $688.00K 10-Q · filed 2026-08-11 | $2.37M derived: sum of 2 quarters · filed 2026-08-11 | |||
| 2026-03-31 | $1.68M 10-Q · filed 2026-08-11 | ||||
| 2025-12-31 | $6.85M 10-K · filed 2026-03-17 | ||||
| 2025-09-30 | $1.41M 10-Q · filed 2025-11-04 | $3.22M derived: sum of 2 quarters · filed 2026-08-11 | $4.67M derived: sum of 3 quarters · filed 2026-08-11 | ||
| 2025-06-30 | $1.81M 10-Q · filed 2026-08-11 | $3.26M derived: sum of 2 quarters · filed 2026-08-11 | |||
| 2025-03-31 | $1.44M 10-Q · filed 2026-08-11 | ||||
| 2024-12-31 | $5.60M 10-K · filed 2026-03-17 | ||||
| 2024-09-30 | $1.42M 10-Q · filed 2025-11-04 | $2.98M derived: sum of 2 quarters · filed 2025-11-04 | $4.32M derived: sum of 3 quarters · filed 2025-11-04 | ||
| 2024-06-30 | $1.56M 10-Q · filed 2025-11-04 | $2.90M derived: sum of 2 quarters · filed 2025-11-04 | |||
| 2024-03-31 | $1.34M 10-Q · filed 2025-11-04 | ||||
| 2023-12-31 | $7.32M 10-K · filed 2026-03-17 | ||||
| 2023-09-30 | $14.74K 8-K/A · filed 2025-02-06 | $1.85M 10-Q · filed 2023-11-07 | $528.52K derived: sum of 2 quarters · filed 2025-02-06 | $591.47K derived: sum of 3 quarters · filed 2025-02-06 | |
| 2023-06-30 | $513.78K 8-K/A · filed 2025-02-06 | $2.03M 10-Q · filed 2023-08-08 | $576.73K derived: sum of 2 quarters · filed 2025-02-06 | ||
| 2023-03-31 | $62.95K 8-K/A · filed 2025-02-06 | $1.80M 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | $8.75M 10-K · filed 2025-03-27 | ||||
| 2022-09-30 | $2.18M 10-Q · filed 2023-11-07 | $4.38M derived: sum of 2 quarters · filed 2023-11-07 | $6.63M derived: sum of 3 quarters · filed 2023-11-07 | ||
| 2022-06-30 | $2.20M 10-Q · filed 2023-11-07 | $4.46M derived: sum of 2 quarters · filed 2023-11-07 | |||
| 2022-03-31 | $2.25M 10-Q · filed 2023-11-07 | ||||
| 2021-12-31 | $7.87M 10-K · filed 2024-03-08 | ||||
| 2021-09-30 | $1.96M 10-Q · filed 2022-11-08 | $3.97M derived: sum of 2 quarters · filed 2022-11-08 | $6.17M derived: sum of 3 quarters · filed 2022-11-08 | ||
| 2021-06-30 | $2.01M 10-Q · filed 2022-11-08 | $4.21M derived: sum of 2 quarters · filed 2022-11-08 | |||
| 2021-03-31 | $2.20M 10-Q · filed 2022-11-08 | ||||
| 2020-12-31 | $4.40M 10-K · filed 2023-03-07 | ||||
| 2020-09-30 | $1.05M 10-Q · filed 2021-11-09 | $1.69M derived: sum of 2 quarters · filed 2021-11-09 | $2.89M derived: sum of 3 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $646.00K 10-Q · filed 2021-11-09 | $1.84M derived: sum of 2 quarters · filed 2021-11-09 | |||
| 2020-03-31 | $1.20M 10-Q · filed 2021-11-09 | ||||
| 2019-12-31 | $3.43M 10-K · filed 2022-03-08 | ||||
| 2019-09-30 | $935.00K 10-Q · filed 2020-11-02 | $1.96M derived: sum of 2 quarters · filed 2020-11-02 | $2.46M derived: sum of 3 quarters · filed 2020-11-02 | ||
| 2019-06-30 | $1.02M 10-Q · filed 2020-11-02 | $1.52M derived: sum of 2 quarters · filed 2020-11-02 | |||
| 2019-03-31 | $501.00K 10-Q · filed 2020-11-02 | ||||
| 2018-12-31 | $1.74M 10-K · filed 2021-03-02 | ||||
| 2018-09-30 | $1.03M 10-Q · filed 2019-11-05 | $1.22M derived: sum of 2 quarters · filed 2019-11-05 | $1.36M derived: sum of 3 quarters · filed 2019-11-05 | ||
| 2018-06-30 | $192.00K 10-Q · filed 2019-11-05 | $336.00K 10-Q · filed 2018-08-14 | |||
| 2018-03-31 | $144.00K 10-Q · filed 2019-11-05 | ||||
| 2017-12-31 | $496.00K 10-K · filed 2020-03-03 | ||||
| 2016-12-31 | $161.00K 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |